)
Aardvark Therapeutics (AARD) investor relations material
Aardvark Therapeutics Stifel 2025 Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Program overview and clinical development
Lead program ARD-101 is a gut-restricted oral small molecule targeting gut-brain signaling to reduce hunger and improve metabolic outcomes, with primary focus on Prader-Willi syndrome.
Phase 2 data in Prader-Willi showed rapid and significant reduction in hyperphagia scores, with additional benefits in anxiety and inflammation.
Phase 3 HERO trial is ongoing, with top-line results expected in Q3 2026; trial design includes measures to reduce placebo response and broaden patient eligibility.
Enrollment is progressing well, with global sites and strong engagement from advocacy groups.
ARD-101 is excluded for patients on contemporaneous Vycat, but prior Vycat use is allowed after a washout period.
Mechanism of action and scientific rationale
ARD-101 activates gut enteroendocrine cells, releasing hormones like CCK, GLP-1, and GIP, which act via vagal signaling to reduce both hunger and appetite.
The approach is distinct from GLP-1 drugs, which mainly reduce appetite but not hunger; ARD-101 addresses the hunger-driven phenotype of Prader-Willi.
Clinical and inferential data suggest Prader-Willi patients have deficient gut-brain signaling, supporting the drug's mechanism.
Dose selection was informed by phase 2 data, with 800 mg b.i.d. chosen to ensure consistent target engagement.
Comparative data and trial design
Phase 2 open-label data showed a mean reduction of minus eight in HQCT scores over 28 days, exceeding typical placebo and competitor results.
Secondary endpoints include anxiety, metabolic biomarkers, and body composition; phase 2 showed 1.5% body fat reduction and 2% lean mass gain.
Phase 3 design includes a second baseline to minimize placebo effect and is powered for robust statistical confidence, with interim sample size re-estimation planned.
Next Aardvark Therapeutics earnings date
Next Aardvark Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)